Management prioritizes 5%–10% weight loss and acetazolamide titration guided by Frisén grading, OCT, and visual fields; refractory or vision-threatening disease may need ONSF or CSF shunting.
The introduction of the first disease-modifying therapies fundamentally transformed the management of geographic atrophy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results